R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_qualifier Arg1:T4 Arg2:T3	
*	OR T5 T6 T7
R3	AND Arg1:T5 Arg2:T4	
*	OR T10 T12
R4	Has_negation Arg1:T10 Arg2:T11	
*	OR T15 T16
*	OR T17 T18
R5	Has_multiplier Arg1:T15 Arg2:T14	
R6	AND Arg1:T17 Arg2:T15	
R7	Has_value Arg1:T21 Arg2:T22	
R8	AND Arg1:T23 Arg2:T21	
R9	Has_value Arg1:T25 Arg2:T26	
R10	AND Arg1:T24 Arg2:T25	
T1	Person 0 3	Age
T2	Value 4 13	=18 years
T3	Qualifier 50 55	acute
T4	Condition 56 58	PE
T5	Procedure 76 90	CT angiography
T6	Procedure 92 123	ventilation/perfusion lung scan
T7	Procedure 138 169	invasive pulmonary angiography,
T8	Condition 244 264	deep vein thrombosis
T10	Condition 277 297	hemodynamic collapse
T11	Negation 266 273	Absence
T12	Condition 277 288;302 316	hemodynamic decompensation
T14	Multiplier 375 387	At least one
T15	Condition 388 416	sign of RV pressure overload
T16	Condition 388 407;417 428	sign of RV pressure dysfunction
T17	Procedure 432 446	CT angiography
T18	Procedure 450 466	echocardiography
T21	Measurement 520 535	troponin levels
T22	Value 511 519	elevated
T23	Condition 477 494	myocardial injury
T24	Condition 547 558	RV) failure
T25	Measurement 575 591	NT-proBNP levels
T26	Value 592 602	>600 pg/ml
T27	Post-eligibility 617 827	Ability of the subject to understand the character and individual consequences of the clinical trial; signed and dated informed consent of the subject available before the start of any specific trial procedures
